Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

Tailor your resume to this Associate Director, New Product Planning & Companion Diagnostics, Japan role.

Rezi rewrites your resume against Revolution Medicines's job description. Free.

Resume score gauge reading 58 out of 100

Don't guess if your resume is good enough.

See how it scores against the Associate Director, New Product Planning & Companion Diagnostics, Japan posting at Revolution Medicines — free, in seconds.

About the Role

The Associate Director, New Product Planning & Compound Strategy will lead commercial discipline for Revolution Medicines' pipelines in Japan, focusing on compound strategy, new product planning, and companion diagnostic (CDx) strategy to maximize commercial potential and enable successful commercialization of precision oncology therapies.

Responsibilities

Lead Japan commercial discipline across cross-functional teams to develop integrated Japan compound strategies for pipeline assets.
Develop compound-specific commercial strategies, incorporating customer insights, competitive intelligence, market dynamics, biomarker strategies, lifecycle planning, and portfolio prioritization.
Partner with Global Commercial, Clinical Development, Medical Affairs, and Market Access to influence Target Product Profiles (TPPs), indication sequencing, evidence generation priorities, lifecycle management, and commercialization strategies.
Identify complex commercial opportunities and business challenges impacting commercial success and translate insights into actionable strategic recommendations.
Lead commercial assessments, forecasting assumptions, scenario planning, and business case development.
Co-lead Japan new product planning activities from late-stage clinical development through commercialization.
Support the development of integrated launch strategies, including customer segmentation, value proposition, positioning, messaging, and go-to-market planning.
Partner across disciplines to establish launch readiness plans, milestone management, risk assessment, and mitigation strategies.
Integrate customer, patient, market, and competitive insights into strategic recommendations and launch planning.
Partner with Market Access to ensure pricing, reimbursement, and patient access considerations are incorporated into commercial strategy and launch readiness.
Own the preparation of Japan Commercial inputs to annual operating plans, long-range planning, commercial forecasts, and strategic investment decisions for pipeline assets.
Lead the development and execution of Japan companion diagnostic (CDx) strategies across disease states.
Develop integrated patient identification strategies, biomarker adoption plans, and testing pathway optimization.
Serve as the primary commercial point of contact for Japan diagnostic partners and lead strategic collaborations.
Provide cross-functional leadership to align Commercial, Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, Global Diagnostics, and external diagnostic partners on CDx development and commercialization strategies.
Shape the companion diagnostic landscape across disease states by influencing testing policies, diagnostic pathways, biomarker adoption, and strategic collaborations.
Represent Japan Commercial in Global companion diagnostic governance to ensure alignment of Japan market needs with global CDx strategies.

Requirements

Minimum of 10 years of progressive pharmaceutical and/or biotechnology commercial experience required.
Minimum of 3 years of Oncology Marketing, New Product Planning, Early Commercial, or Commercial Strategy experience required.
Demonstrated experience in Companion Diagnostics (CDx), biomarker-driven oncology, or precision medicine required.
Proven product launch experience required.
Demonstrated experience developing compound strategies, commercial assessments, portfolio strategies, lifecycle management, or launch strategies for pipeline assets preferred.
Strong understanding of the oncology ecosystem, including patients, healthcare professionals, institutions, payers, diagnostic stakeholders, and biomarker testing pathways.
Demonstrated ability to provide leadership across disciplines and influence cross-functional teams in a matrix environment without direct authority.
Proven ability to identify and resolve highly complex business challenges and translate strategic insights into commercial recommendations.
Strong strategic thinking, analytical, forecasting, and business planning capabilities with a track record of driving business impact beyond the immediate function.
Excellent communication, presentation, negotiation, and stakeholder management skills.
Entrepreneurial mindset with the ability to thrive in a dynamic, fast-growing biotechnology environment.
Fluency in Japanese and business-level English required.

Skills

Compound Strategy
Portfolio Planning
New Product Planning
Launch Readiness
Companion Diagnostics Strategy
Oncology Marketing
Commercial Strategy
Biomarker-driven oncology
Precision medicine
Product launch
Lifecycle management
Forecasting
Business planning
Stakeholder management

Location

Tokyo, Japan

Work Type

Hybrid

Experience Level

Associate Director
Minimum of 10 years of progressive pharmaceutical and/or biotechnology commercial experience
Minimum of 3 years of Oncology Marketing, New Product Planning, Early Commercial, or Commercial Strategy experience

Education Level

Bachelor's degree required
Advanced degree (MBA, PharmD, PhD, MSc, or equivalent) preferred

About the Company

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers.
Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.
Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

Equal Opportunity

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.